II BRAZILIAN CONSENSUS ON GASTRIC CANCER BY THE BRAZILIAN GASTRIC CANCER ASSOCIATION
Carregando...
Citações na Scopus
17
Tipo de produção
article
Data de publicação
2020
Título da Revista
ISSN da Revista
Título do Volume
Editora
COLEGIO BRASILEIRO CIRURGIA DIGESTIVA-CBCD
Autores
ANDREOLLO, Nelson Adami
WESTON, Antonio Carlos
LOURENCO, Laercio Gomes
MALHEIROS, Carlos Alberto
KASSAB, Paulo
Citação
ABCD-ARQUIVOS BRASILEIROS DE CIRURGIA DIGESTIVA-BRAZILIAN ARCHIVES OF DIGESTIVE SURGERY, v.33, n.2, article ID e1514, 8p, 2020
Resumo
Background: Since the publication of the first Brazilian Consensus on Gastric Cancer (GC) in 2012 carried out by the Brazilian Gastric Cancer Association, new concepts on diagnosis, staging, treatment and follow-up have been incorporated. Aim: This new consensus is to promote an update to professionals working in the fight against GC and to provide guidelines for the management of patients with this condition. Methods: Fifty-nine experts answered 67 statements regarding the diagnosis, staging, treatment and prognosis of GC with five possible alternatives: 1) fully agree; 2) partially agree; 3) undecided; 4) disagree and 5) strongly disagree A consensus was adopted when at least 80% of the sum of the answers ""fully agree"" and ""partially agree"" was reached. This article presents only the responses of the participating experts. Comments on each statement, as well as a literature review, will be presented in future publications. Results: Of the 67 statements, there was consensus in 50 (74%). In 10 declarations, there was 100% agreement. Conclusion: The gastric cancer treatment has evolved considerably in recent years. This consensus gathers consolidated principles in the last decades, new knowledge acquired recently, as well as promising perspectives on the management of this disease.
Palavras-chave
Gastric neoplasms, Gastric cancer, Gastrectomy, Lymphadenectomy, Consensus, Adenocarcinoma, Neoplasias gástricas, Câncer gástrico, Gastrectomia, Linfadenectomia, Consenso. Adenocarcinoma
Referências
- Ajani JA, 2016, J NATL COMPR CANC NE, V14, P1286, DOI 10.6004/jnccn.2016.0137
- Amorim CA, 2014, WORLD J GASTROENTERO, V20, P5036, DOI 10.3748/wjg.v20.i17.5036
- Association JGC, 2020, GASTRIC CANC
- Baiocchi GL, 2016, GASTRIC CANCER, V19, P15, DOI 10.1007/s10120-015-0513-0
- Barchi LC, 2012, ABCD-ARQ BRAS CIR DI, V25, P300, DOI 10.1590/S0102-67202012000400018
- Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI 10.3322/caac.21492
- Council of Europe, 2002, DEV METH DRAW GUID O
- De Manzoni G, 2017, GASTRIC CANCER, V20, P20, DOI 10.1007/s10120-016-0615-3
- Dias AR, 2017, ABCD-ARQ BRAS CIR DI, V30, P150, DOI 10.1590/0102-6720201700020016
- Figueroa-Giralt M, 2019, ABCD-ARQ BRAS CIR DI, V32, DOI 10.1590/0102-672020190001e1441
- Instituto Nacional de Cancer Jose Alencar Gomes da Silva (INCA), 2018, EST 2018 INC BRAS
- Ramos MFKP, 2019, ABCD-ARQ BRAS CIR DI, V32, DOI 10.1590/0102-672020190001e1435
- Kulig Jan, 2017, Pol Przegl Chir, V89, P59, DOI 10.5604/01.3001.0010.5413
- Lee JH, 2014, J GASTRIC CANCER, V14, P87, DOI [10.5230/jgc.2014.14.2.87, 10.7583/JKGS.2014.14.5.87]
- Moore MA, 2010, ASIAN PAC J CANCER P, V11, P17
- Norero E, 2019, ABCD-ARQ BRAS CIR DI, V32, DOI 10.1590/0102-672020190001e1473
- Peduk S, 2018, ABCD-ARQ BRAS CIR DI, V31, DOI 10.1590/0102-672020180001e1401
- Sano T, 2017, GASTRIC CANCER, V20, P217, DOI 10.1007/s10120-016-0601-9
- Smyth EC, 2016, ANN ONCOL, V27, pv38, DOI 10.1093/annonc/mdw350
- Wang FH, 2019, CANCER COMMUN, V39, DOI 10.1186/s40880-019-0349-9
- Zaanan A, 2018, DIGEST LIVER DIS, V50, P768, DOI 10.1016/j.dld.2018.04.025
- Zilberstein B, 2013, ABCD-ARQ BRAS CIR DI, V26, P2, DOI 10.1590/S0102-67202013000100002